Highlights
KLSE: HARTA (5168)       HARTALEGA HOLDINGS BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
14.50   -0.16 (1.09%)  14.46 - 14.70  2,329,100
Trade this stock with T+7 trading account. Find out more.

Financials


Market Cap: 49,700 Million

Market Cap 49,700 Million
NOSH 3,428 Million

Latest Audited Result:  31-Mar-2020

Latest Audited Result: 31-Mar-2020
Announcement Date 30-Jul-2020
Next Audited Result: 31-Mar-2021
Est. Ann. Date: 30-Jul-2021
Est. Ann. Due Date: 27-Sep-2021

Latest Quarter:  30-Sep-2020 [#2]

Latest Quarter: 30-Sep-2020 [#2]
Announcement Date 27-Oct-2020
Next Quarter: 31-Dec-2020
Est. Ann. Date: 11-Feb-2021
Est. Ann. Due Date: 01-Mar-2021
QoQ | YoY   148.02%  |    424.67%

Annual (Unaudited) ( EPS: 12.68, P/E: 114.31 )

Revenue | NP to SH 2,923,973  |  434,782
RPS | P/RPS 85.31 Cent  |  17.00
EPS | P/E | EY 12.68 Cent  |  114.31  |  0.87%
DPS | DY | Payout % 7.41 Cent  |  0.51%  |  58.45%
NAPS | P/NAPS 0.74  |  19.69
YoY   -4.70%
NP Margin | ROE 14.91%  |  17.22%
F.Y. | Ann. Date 31-Mar-2020  |  18-May-2020

T4Q Result ( EPS: 29.22, P/E: 49.62 )

Revenue | NP to SH 3,840,551  |  1,001,529
RPS | P/RPS 112.05 Cent  |  12.94
EPS | P/E | EY 29.22 Cent  |  49.62  |  2.02%
DPS | DY | Payout % 9.66 Cent  |  0.67%  |  33.05%
NAPS | P/NAPS 0.98  |  14.84
QoQ | YoY   78.70%  |    144.85%
NP Margin | ROE 26.25%  |  29.90%
F.Y. | Ann. Date 30-Sep-2020  |  27-Oct-2020

Annualized Result ( EPS: 44.62, P/E: 32.50 )

Revenue | NP to SH 4,532,206  |  1,529,354
RPS | P/RPS 132.23 Cent  |  10.97
EPS | P/E | EY 44.62 Cent  |  32.50  |  3.08%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   74.01%  |    286.34%
NP Margin | ROE 34.01%  |  45.66%
F.Y. | Ann. Date 30-Sep-2020  |  27-Oct-2020




Show?  YoY % Horiz. %

Last 10 FY Result
AQR T4Q 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Revenue 4,532,206 3,840,551 2,923,973 2,827,879 2,405,638 1,821,873 1,498,337 1,145,960 1,107,079 1,032,036 931,064 734,921 16.57%
  YoY % 18.01% 31.35% 3.40% 17.55% 32.04% 21.59% 30.75% 3.51% 7.27% 10.84% 26.69% -
  Horiz. % 616.69% 522.58% 397.86% 384.79% 327.33% 247.90% 203.88% 155.93% 150.64% 140.43% 126.69% 100.00%
PBT 1,911,560 1,253,052 556,253 551,866 526,810 348,977 316,878 276,881 308,951 304,099 258,404 242,834 9.64%
  YoY % 52.55% 125.27% 0.79% 4.76% 50.96% 10.13% 14.45% -10.38% 1.60% 17.68% 6.41% -
  Horiz. % 787.19% 516.01% 229.07% 227.26% 216.94% 143.71% 130.49% 114.02% 127.23% 125.23% 106.41% 100.00%
Tax -370,044 -244,922 -120,421 -95,648 -86,621 -65,660 -59,118 -66,674 -75,658 -70,506 -56,972 -52,510 9.65%
  YoY % -51.09% -103.39% -25.90% -10.42% -31.92% -11.07% 11.33% 11.87% -7.31% -23.76% -8.50% -
  Horiz. % 704.71% 466.43% 229.33% 182.15% 164.96% 125.04% 112.58% 126.97% 144.08% 134.27% 108.50% 100.00%
NP 1,541,516 1,008,130 435,832 456,218 440,189 283,317 257,760 210,207 233,293 233,593 201,432 190,324 9.63%
  YoY % 52.91% 131.31% -4.47% 3.64% 55.37% 9.92% 22.62% -9.90% -0.13% 15.97% 5.84% -
  Horiz. % 809.94% 529.69% 228.99% 239.71% 231.28% 148.86% 135.43% 110.45% 122.58% 122.73% 105.84% 100.00%
NP to SH 1,529,354 1,001,529 434,782 456,204 439,395 283,001 257,428 209,733 232,813 233,337 201,380 190,297 9.61%
  YoY % 52.70% 130.35% -4.70% 3.83% 55.26% 9.93% 22.74% -9.91% -0.22% 15.87% 5.82% -
  Horiz. % 803.67% 526.30% 228.48% 239.73% 230.90% 148.72% 135.28% 110.21% 122.34% 122.62% 105.82% 100.00%
Tax Rate 19.36 % 19.55 % 21.65 % 17.33 % 16.44 % 18.81 % 18.66 % 24.08 % 24.49 % 23.19 % 22.05 % 21.62 % 0.02%
  YoY % -0.97% -9.70% 24.93% 5.41% -12.60% 0.80% -22.51% -1.67% 5.61% 5.17% 1.99% -
  Horiz. % 89.55% 90.43% 100.14% 80.16% 76.04% 87.00% 86.31% 111.38% 113.27% 107.26% 101.99% 100.00%
Total Cost 2,990,690 2,832,421 2,488,141 2,371,661 1,965,449 1,538,556 1,240,577 935,753 873,786 798,443 729,632 544,597 18.37%
  YoY % 5.59% 13.84% 4.91% 20.67% 27.75% 24.02% 32.58% 7.09% 9.44% 9.43% 33.98% -
  Horiz. % 549.16% 520.09% 456.88% 435.49% 360.90% 282.51% 227.80% 171.82% 160.45% 146.61% 133.98% 100.00%
Net Worth 3,349,579 3,349,579 2,524,266 2,228,470 1,983,748 837,311 1,500,642 61,480,642 935,616 761,566 309,724 494,505 19.84%
  YoY % 0.00% 32.70% 13.27% 12.34% 136.92% -44.20% -97.56% 6,471.14% 22.85% 145.89% -37.37% -
  Horiz. % 677.36% 677.36% 510.46% 450.65% 401.16% 169.32% 303.46% 12,432.74% 189.20% 154.01% 62.63% 100.00%
Dividend
AQR T4Q 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Div 402,626 330,958 254,109 282,716 231,437 65,671 131,175 50,483 107,559 102,370 43,694 76,340 14.28%
  YoY % 21.65% 30.24% -10.12% 22.16% 252.42% -49.94% 159.84% -53.06% 5.07% 134.29% -42.76% -
  Horiz. % 527.41% 433.53% 332.86% 370.34% 303.16% 86.02% 171.83% 66.13% 140.89% 134.10% 57.24% 100.00%
Div Payout % 26.33 % 33.05 % 58.45 % 61.97 % 52.67 % 23.21 % 50.96 % 24.07 % 46.20 % 43.87 % 21.70 % 40.12 % 4.27%
  YoY % -20.33% -43.46% -5.68% 17.66% 126.93% -54.45% 111.72% -47.90% 5.31% 102.17% -45.91% -
  Horiz. % 65.63% 82.38% 145.69% 154.46% 131.28% 57.85% 127.02% 60.00% 115.15% 109.35% 54.09% 100.00%
Equity
AQR T4Q 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Net Worth 3,349,579 3,349,579 2,524,266 2,228,470 1,983,748 837,311 1,500,642 61,480,642 935,616 761,566 309,724 494,505 19.84%
  YoY % 0.00% 32.70% 13.27% 12.34% 136.92% -44.20% -97.56% 6,471.14% 22.85% 145.89% -37.37% -
  Horiz. % 677.36% 677.36% 510.46% 450.65% 401.16% 169.32% 303.46% 12,432.74% 189.20% 154.01% 62.63% 100.00%
NOSH 3,383,414 3,383,414 3,365,688 3,326,075 3,306,247 1,641,786 1,639,688 776,662 741,787 731,221 364,124 363,527 28.03%
  YoY % 0.00% 0.53% 1.19% 0.60% 101.38% 0.13% 111.12% 4.70% 1.45% 100.82% 0.16% -
  Horiz. % 930.72% 930.72% 925.84% 914.95% 909.49% 451.63% 451.05% 213.65% 204.05% 201.15% 100.16% 100.00%
Ratio Analysis
AQR T4Q 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
NP Margin 34.01 % 26.25 % 14.91 % 16.13 % 18.30 % 15.55 % 17.20 % 18.34 % 21.07 % 22.63 % 21.63 % 25.90 % -5.95%
  YoY % 29.56% 76.06% -7.56% -11.86% 17.68% -9.59% -6.22% -12.96% -6.89% 4.62% -16.49% -
  Horiz. % 131.31% 101.35% 57.57% 62.28% 70.66% 60.04% 66.41% 70.81% 81.35% 87.37% 83.51% 100.00%
ROE 45.66 % 29.90 % 17.22 % 20.47 % 22.15 % 33.80 % 17.15 % 0.34 % 24.88 % 30.64 % 65.02 % 38.48 % -8.54%
  YoY % 52.71% 73.64% -15.88% -7.58% -34.47% 97.08% 4,944.12% -98.63% -18.80% -52.88% 68.97% -
  Horiz. % 118.66% 77.70% 44.75% 53.20% 57.56% 87.84% 44.57% 0.88% 64.66% 79.63% 168.97% 100.00%
Per Share
AQR T4Q 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 133.95 113.51 86.88 85.02 72.76 110.97 91.38 147.55 149.24 141.14 255.70 202.16 -8.95%
  YoY % 18.01% 30.65% 2.19% 16.85% -34.43% 21.44% -38.07% -1.13% 5.74% -44.80% 26.48% -
  Horiz. % 66.26% 56.15% 42.98% 42.06% 35.99% 54.89% 45.20% 72.99% 73.82% 69.82% 126.48% 100.00%
EPS 44.76 29.60 12.92 13.72 13.29 8.62 15.70 13.48 31.39 31.88 27.65 52.35 -14.39%
  YoY % 51.22% 129.10% -5.83% 3.24% 54.18% -45.10% 16.47% -57.06% -1.54% 15.30% -47.18% -
  Horiz. % 85.50% 56.54% 24.68% 26.21% 25.39% 16.47% 29.99% 25.75% 59.96% 60.90% 52.82% 100.00%
DPS 11.90 9.80 7.55 8.50 7.00 4.00 8.00 6.50 14.50 14.00 12.00 21.00 -10.73%
  YoY % 21.43% 29.80% -11.18% 21.43% 75.00% -50.00% 23.08% -55.17% 3.57% 16.67% -42.86% -
  Horiz. % 56.67% 46.67% 35.95% 40.48% 33.33% 19.05% 38.10% 30.95% 69.05% 66.67% 57.14% 100.00%
NAPS 0.9900 0.9900 0.7500 0.6700 0.6000 0.5100 0.9152 79.1600 1.2613 1.0415 0.8506 1.3603 -6.40%
  YoY % 0.00% 32.00% 11.94% 11.67% 17.65% -44.27% -98.84% 6,176.06% 21.10% 22.44% -37.47% -
  Horiz. % 72.78% 72.78% 55.13% 49.25% 44.11% 37.49% 67.28% 5,819.31% 92.72% 76.56% 62.53% 100.00%
Adjusted Per Share Value based on latest NOSH - 3,427,606
AQR T4Q 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 132.23 112.05 85.31 82.50 70.18 53.15 43.71 33.43 32.30 30.11 27.16 21.44 16.57%
  YoY % 18.01% 31.34% 3.41% 17.55% 32.04% 21.60% 30.75% 3.50% 7.27% 10.86% 26.68% -
  Horiz. % 616.74% 522.62% 397.90% 384.79% 327.33% 247.90% 203.87% 155.92% 150.65% 140.44% 126.68% 100.00%
EPS 44.62 29.22 12.68 13.31 12.82 8.26 7.51 6.12 6.79 6.81 5.88 5.55 9.61%
  YoY % 52.70% 130.44% -4.73% 3.82% 55.21% 9.99% 22.71% -9.87% -0.29% 15.82% 5.95% -
  Horiz. % 803.96% 526.49% 228.47% 239.82% 230.99% 148.83% 135.32% 110.27% 122.34% 122.70% 105.95% 100.00%
DPS 11.75 9.66 7.41 8.25 6.75 1.92 3.83 1.47 3.14 2.99 1.27 2.23 14.26%
  YoY % 21.64% 30.36% -10.18% 22.22% 251.56% -49.87% 160.54% -53.18% 5.02% 135.43% -43.05% -
  Horiz. % 526.91% 433.18% 332.29% 369.96% 302.69% 86.10% 171.75% 65.92% 140.81% 134.08% 56.95% 100.00%
NAPS 0.9772 0.9772 0.7365 0.6502 0.5788 0.2443 0.4378 17.9369 0.2730 0.2222 0.0904 0.1443 19.84%
  YoY % 0.00% 32.68% 13.27% 12.34% 136.92% -44.20% -97.56% 6,470.29% 22.86% 145.80% -37.35% -
  Horiz. % 677.20% 677.20% 510.40% 450.59% 401.11% 169.30% 303.40% 12,430.28% 189.19% 153.98% 62.65% 100.00%
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date AQR T4Q 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 -
Price 16.2000 16.2000 6.8800 4.6300 6.0500 4.9600 4.8500 8.6700 6.8500 4.9400 6.6200 4.5400 -
P/RPS 12.09 14.27 7.92 5.45 8.31 4.47 5.31 5.88 4.59 3.50 2.59 2.25 14.99%
  YoY % -15.28% 80.18% 45.32% -34.42% 85.91% -15.82% -9.69% 28.10% 31.14% 35.14% 15.11% -
  Horiz. % 537.33% 634.22% 352.00% 242.22% 369.33% 198.67% 236.00% 261.33% 204.00% 155.56% 115.11% 100.00%
P/EPS 35.84 54.73 53.26 33.76 45.52 28.77 30.89 32.11 21.83 15.48 11.97 8.67 22.33%
  YoY % -34.51% 2.76% 57.76% -25.83% 58.22% -6.86% -3.80% 47.09% 41.02% 29.32% 38.06% -
  Horiz. % 413.38% 631.26% 614.30% 389.39% 525.03% 331.83% 356.29% 370.36% 251.79% 178.55% 138.06% 100.00%
EY 2.79 1.83 1.88 2.96 2.20 3.48 3.24 3.11 4.58 6.46 8.35 11.53 -18.24%
  YoY % 52.46% -2.66% -36.49% 34.55% -36.78% 7.41% 4.18% -32.10% -29.10% -22.63% -27.58% -
  Horiz. % 24.20% 15.87% 16.31% 25.67% 19.08% 30.18% 28.10% 26.97% 39.72% 56.03% 72.42% 100.00%
DY 0.73 0.60 1.10 1.84 1.16 0.81 1.65 0.75 2.12 2.83 1.81 4.63 -14.75%
  YoY % 21.67% -45.45% -40.22% 58.62% 43.21% -50.91% 120.00% -64.62% -25.09% 56.35% -60.91% -
  Horiz. % 15.77% 12.96% 23.76% 39.74% 25.05% 17.49% 35.64% 16.20% 45.79% 61.12% 39.09% 100.00%
P/NAPS 16.36 16.36 9.17 6.91 10.08 9.73 5.30 0.11 5.43 4.74 7.78 3.34 11.86%
  YoY % 0.00% 78.41% 32.71% -31.45% 3.60% 83.58% 4,718.18% -97.97% 14.56% -39.07% 132.93% -
  Horiz. % 489.82% 489.82% 274.55% 206.89% 301.80% 291.32% 158.68% 3.29% 162.57% 141.92% 232.93% 100.00%
Price Multiplier on Announcement Date
AQR T4Q 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date AQR T4Q - 07/05/19 15/05/18 09/05/17 03/05/16 05/05/15 06/05/14 07/05/13 09/05/12 10/05/11 -
Price 18.2800 18.2800 9.1300 5.0500 6.0000 5.3900 4.1400 8.2200 6.0200 5.4500 6.5100 4.7500 -
P/RPS 13.65 16.10 10.51 5.94 8.25 4.86 4.53 5.57 4.03 3.86 2.55 2.35 18.09%
  YoY % -15.22% 53.19% 76.94% -28.00% 69.75% 7.28% -18.67% 38.21% 4.40% 51.37% 8.51% -
  Horiz. % 580.85% 685.11% 447.23% 252.77% 351.06% 206.81% 192.77% 237.02% 171.49% 164.26% 108.51% 100.00%
P/EPS 40.44 61.75 70.68 36.82 45.15 31.27 26.37 30.44 19.18 17.08 11.77 9.07 25.60%
  YoY % -34.51% -12.63% 91.96% -18.45% 44.39% 18.58% -13.37% 58.71% 12.30% 45.11% 29.77% -
  Horiz. % 445.87% 680.82% 779.27% 405.95% 497.79% 344.76% 290.74% 335.61% 211.47% 188.31% 129.77% 100.00%
EY 2.47 1.62 1.41 2.72 2.21 3.20 3.79 3.29 5.21 5.86 8.50 11.02 -20.41%
  YoY % 52.47% 14.89% -48.16% 23.08% -30.94% -15.57% 15.20% -36.85% -11.09% -31.06% -22.87% -
  Horiz. % 22.41% 14.70% 12.79% 24.68% 20.05% 29.04% 34.39% 29.85% 47.28% 53.18% 77.13% 100.00%
DY 0.65 0.54 0.83 1.68 1.17 0.74 1.93 0.79 2.41 2.57 1.84 4.42 -16.94%
  YoY % 20.37% -34.94% -50.60% 43.59% 58.11% -61.66% 144.30% -67.22% -6.23% 39.67% -58.37% -
  Horiz. % 14.71% 12.22% 18.78% 38.01% 26.47% 16.74% 43.67% 17.87% 54.52% 58.14% 41.63% 100.00%
P/NAPS 18.46 18.46 12.17 7.54 10.00 10.57 4.52 0.10 4.77 5.23 7.65 3.49 14.87%
  YoY % 0.00% 51.68% 61.41% -24.60% -5.39% 133.85% 4,420.00% -97.90% -8.80% -31.63% 119.20% -
  Horiz. % 528.94% 528.94% 348.71% 216.05% 286.53% 302.87% 129.51% 2.87% 136.68% 149.86% 219.20% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  8 people like this.
 
Reid Tee Hartalega become harta tak lega, lousy glove stock laaa
30/11/2020 6:12 PM
Pgraduate123 Last week I advised boycott harta, people actually listened and today they jumped to supermax
30/11/2020 6:21 PM
Pgraduate123 Mabel, efficient la, tech la, no use one.
Must goreng like few months ago only can justify efficiency and hi tech ma... Lol
30/11/2020 6:24 PM
PZOGRO RELAX

2 OF HARTA RUBEREX TO CATCH BIG UP TOMORROW

ROTATIONAL PLAYS
30/11/2020 9:23 PM
PZOGRO RECOVERY PLAYS PAUSED TODAY AS BIG FUNDS ADJUSTING PORTFOLIO TAKING PROFITS

PANDEMIC PLAYS TO START BACK TODAT

PUT YOIR CHIPS NICELY AND ENJOYING THE RIDES
30/11/2020 9:25 PM
30/11/2020 11:36 PM
ruhaizat69 Slow slow rilex keep for long term,
01/12/2020 11:38 AM
fofo Dr Noor Hisham said 101 cases were confirmed from the Covid-19-related prison clusters. Of these, four clusters were in Sabah, namely the PTS Sibuga cluster with 65 cases, the PTS Tawau cluster with eight cases, the Matambai cluster with three cases, and the Sandakan prison cluster with one case.
01/12/2020 2:51 PM
proacez2000 GOB also better...stohastic oversold, macd cross...good time to enter now...dont miss the boat..good luck
01/12/2020 3:25 PM
amarjeet8287 Epf is selling kossan and topglove and buying harta in bulk
01/12/2020 7:25 PM
cutie Many die hard glove holders are switching to Harta including epf
01/12/2020 8:05 PM
goreng_kaki harta is a rubbish,
even topglove is on trouble now ....
harta also cannot play a leader role to lead other glove sector up....
02/12/2020 9:03 AM
ruhaizat69 Keep for 52 weeks
02/12/2020 9:53 AM
Kendo Ken Hz Niamah kenaga tp26?
02/12/2020 10:00 AM
hkimbrs Apa cerita?
02/12/2020 12:13 PM
Lewis Lee If good share goes down, don't blame the company, blame all the fucking stupid investors out there !! :)
02/12/2020 1:29 PM
AllYouCanBuy https://www.theedgemarkets.com/node/544103 70% cost up
02/12/2020 2:51 PM
PZOGRO HOT!

KAF

BUY CALLS TO TG & SUPERMX

HOLD CALLS TO HARTA & KOSSAN


https://www.theedgemarkets.com/article/nitrile-latex-could-hit-alltime-high-month-raising-glove-production-costs-70-qoq-%E2%80%94-kaf
02/12/2020 3:04 PM
proacez2000 price already above SMA10....bullish incoming...good luck...best time to enter
02/12/2020 4:44 PM
proacez2000 stohastic slow show reversal, MACD cross, price already above SMA10...rally incoming..good luck...
02/12/2020 4:47 PM
goreng_kaki kenanga tp 16.22 instead of 26.22,
rubbish harta cant even break RM 15
02/12/2020 4:48 PM
pertamina Harta is not suitable for kaki goreng
02/12/2020 5:06 PM
_phoenix_ lmao
----------
pertamina Harta is not suitable for kaki goreng
02/12/2020 5:06 PM
02/12/2020 5:26 PM
Pgraduate123 Sungguh Tak Lega nya
02/12/2020 7:43 PM
partimeshark kenanga Target price 26.22
fast goreng up to 26.22 IB Kenanga
02/12/2020 11:18 PM
WeLoveSarawak i notice, almost all of the "IB losing money" call warrants for the Big 4 have expired..i think only a few left...the rest of the call warrants now are wayyyy "out of the money".
so my expectation is IB will start to goreng-goreng and fry the Big 4 soon..hopefully!!
02/12/2020 11:46 PM
shinrei go go go!
03/12/2020 9:10 AM
ruhaizat69 Rilek slow slow no rushing
03/12/2020 10:52 AM
ChaseBros https://www.theedgemarkets.com/article/top-glove-hartalega-offer-filli...

MIDF Amanah Investment Bank Bhd analysts wrote in a note today that the rubber glove “shortage is likely to persist into 2021 as supply is unlikely to keep up with demand yet” as the world contends with the Covid-19 pandemic.

The analysts said 2020 had been an exceptional year for glove companies due to a surprise surge in demand for rubber gloves following the Covid-19 outbreak.

According to them, the glove industry as a whole is expected to increase production, but that may be constrained by raw material, production line contractor and foreign labour shortages.

"As such, we expect demand to outstrip supply by 30 billion pieces in 2020, 45.8 billion pieces in 2021 and 33.4 billion pieces in 2022.

"In 2021, demand will continue to be supported by mass testing and administration of Covid-19 vaccines when they are available,” the analysts said.
03/12/2020 1:00 PM
PZOGRO HOT!

SUPERMAX IN!

KOSSAN NOT IN!!

FBMKLCI GLOVES WEIGHTING UP!!!

TRUELY BIG3: TOPGLOVE; HARTA; SUPERMAX!!!
03/12/2020 3:02 PM
proacez2000 1 player down=topglove...mean less competition, will contribute increase in sales and profit for hartalega
03/12/2020 3:17 PM
PZOGRO HOT!

1618 BREAKS!

FBMKLCI BULLS BACK IN ACTION!
03/12/2020 3:21 PM
ChaseBros U.S. tops ‘unfathomable’ milestone of 100,000 Covid hospitalizations: ‘We’re all on edge’

PUBLISHED WED, DEC 2 20207:15 PM ESTUPDATED WED, DEC 2 20207:25 PM EST

“We’re running out of beds, and we’re also going to run out of staff,” said Dr. Megan Ranney, an emergency physician and director of the Brown-Lifespan Center for Digital Health.

--------------------------------------------------------------

This is gonna be a brutal winter...................... The vaccine is still in trial, not approved, only may-be granted emergency temporary registration for limited use. In case of emergency use, you'll need to sign no-liability/indemnity letter thus government bear no responsibility and if you develop any Covid vaccine related minor/major sickness now or later, insurance will not cover.

Emergency use is only for morale support, not going to slow-down the number of infections neither death. People need to realize that they need to do their part to contain the virus like China/Taiwan, not merely relying or hoping for a silver-bullet.
03/12/2020 4:15 PM
fofo Sabah reported the second highest number of new Covid-19 infections today with 310 cases, followed by Johor with 78 cases, Negeri Sembilan (52), Penang (43), Kedah (32), Perak (26), Labuan (nine), Kelantan (nine), Pahang (four), Melaka (two), Sarawak (one), and Terengganu (one).
03/12/2020 9:52 PM
fishchu The big four glove makers have also reported more than double earnings growth on a quarterly basis — Top Glove Corp Bhd (+238.5% q-o-q), Kossan Rubber Industries Bhd (+166.1% q-o-q), Hartalega Holdings Bhd (+148.02% q-o-q) and Supermax Corp Bhd (+97.6% q-o-q).
03/12/2020 10:25 PM
speakup Comfort PE 14x
Carepls PE 18x
Supermx PE 18x
Kossan PE 26x
Top Glove PE 30x
Harta PE 50x
HLT PE 91x
03/12/2020 10:40 PM
speakup Rubberex PE 20x
03/12/2020 10:45 PM
shinrei come on harta!!!
03/12/2020 11:38 PM
Aimhigh Take a good look at Hengyuan
04/12/2020 9:19 AM
LaoTzeAhSir R.i.p. Harta-c52, the most manipulated warrant, ever.
04/12/2020 9:38 AM
Aimhigh Hengyuan good fundamentals, rising steadily
04/12/2020 9:52 AM
gloveharicut https://klse.i3investor.com/blogs/gloveharicut/2020-12-04-story-h1537412501-Forwarders_see_their_cargo_bumped_as_vaccine_shipments_take_off.jsp
04/12/2020 11:02 AM
Aimhigh Gloves will be suppressed till don't know when.
04/12/2020 12:48 PM
Aimhigh Hengyuan is the next rocket I believe. Anyone bought it this morning?
04/12/2020 12:49 PM
CHONGweiboon1119 I bought petronm instead of hengyuan in April at 4.6, dont know how far to go. Should I take profit and just let it run. Sorry to disturb forum here
04/12/2020 1:04 PM
LaoTzeAhSir the harta-C52 market maker and many others who manipulate with the premium games, beware of how you songlap people money, you think you're smart, but you don't believe in karma.
04/12/2020 3:14 PM
longinvest GENEVA: United Nations Secretary-General Antonio Guterres warned on Thursday (Dec 3) that the world could be fighting the aftershocks of the COVID-19 pandemic for decades to come even if vaccines are quickly approved.

Opening a special UN summit on the virus, being held virtually as a safety precaution, Guterres hailed the quick scientific progress but cautioned that vaccination was not a panacea for the ills affecting the planet.

https://www.channelnewsasia.com/news/world/covid-19-un-chief-warns-long-road-ahead-after-vaccines-approval-13693588?cid=FBcna&fbclid=IwAR2Wv64aE9MOls5roH-E3CeLa55WhSVNSKgPP7dqWiImZtzVDpMA_ijHitY
04/12/2020 4:00 PM
proacez2000 best time to buy is now...dont know how to read chart ka? major indicator show buying signal...only stupid will sell...blue chip stock is not for short term holder...only medium to long term only can...if you want big fast profit go to penny stock...hahahaha
04/12/2020 11:17 PM
fofo Health director-general Tan Sri Dr Noor Hisham today announced eight new Covid-19 clusters with a total of 104 infections, while four clusters have been declared ended as no new cases recorded within 28 days.
04/12/2020 11:31 PM
fofo The new clusters are:
The Muda construction site cluster involving Titiwangsa, Lembah Pantai and Kepong in Kuala Lumpur (11 cases)
The Galeri construction site cluster spanning Lembah Pantai and Cheras in Kuala Lumpur (16 cases)
The Bukit Dalam cluster in Lembah Pantai, Kuala Lumpur (13 cases)
The Cempaka cluster involving Kulai and Kluang in Johor (10 cases)
The Sungai Cincin cluster spanning Batang Padang in Perak, Segamat in Johor and Klang in Selangor (15 cases)
The Huma cluster involving Pasir Puteh and Kota Bharu in Kelantan (20 cases)
The Jalan Genting cluster involving Titiwangsa in Kuala Lumpur and Bentong in Pahang (14 cases)
The Atabara cluster involving Kuantan and Pekan in Pahang (five cases)
04/12/2020 11:31 PM